Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...

Teva Pharmaceutical ( (TEVA)) has provided an update. Teva Pharmaceutical Industries has appointed Chen Lichtenstein as a new independent Board member, effective December 1, 2024. With a robust ...

The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...

Upon halting the shipment, customs officers conducted a thorough inspection and uncovered a large quantity of capsules totaling around 60,000 units of Lyrica, a narcotic substance. The seized capsules ...

Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), boosting ...

One company to watch right now is Teva Pharmaceutical Industries (TEVA). TEVA is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock has a Forward P/E ratio of ...

2024 EPS Guidance: Raised to $2.40 to $2.50. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported a 15% increase in revenues, reaching $4.3 billion for Q3 2024. The company's innovative ...

Financial giants have made a conspicuous bearish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE:TEVA) revealed 9 unusual trades. Delving ...